PT2389937T - Composição farmacêutica para melhorar as funções cerebrais - Google Patents
Composição farmacêutica para melhorar as funções cerebraisInfo
- Publication number
- PT2389937T PT2389937T PT11006318T PT11006318T PT2389937T PT 2389937 T PT2389937 T PT 2389937T PT 11006318 T PT11006318 T PT 11006318T PT 11006318 T PT11006318 T PT 11006318T PT 2389937 T PT2389937 T PT 2389937T
- Authority
- PT
- Portugal
- Prior art keywords
- cerebral
- ingredient
- integer
- optionally substituted
- hydroxyl group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002173483 | 2002-06-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2389937T true PT2389937T (pt) | 2018-10-26 |
Family
ID=29727916
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT11006318T PT2389937T (pt) | 2002-06-14 | 2003-04-03 | Composição farmacêutica para melhorar as funções cerebrais |
| PT03760132T PT1514542E (pt) | 2002-06-14 | 2003-04-03 | Composição medicamentosa incluindo tacrina ou donepezilo para melhorar as funções cerebrais |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT03760132T PT1514542E (pt) | 2002-06-14 | 2003-04-03 | Composição medicamentosa incluindo tacrina ou donepezilo para melhorar as funções cerebrais |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | USRE42327E1 (pt) |
| EP (2) | EP1514542B1 (pt) |
| JP (1) | JP4675103B2 (pt) |
| KR (1) | KR100935615B1 (pt) |
| CN (1) | CN100375619C (pt) |
| AT (1) | ATE546140T1 (pt) |
| AU (1) | AU2003236364C1 (pt) |
| BR (1) | BRPI0311780B8 (pt) |
| CA (1) | CA2488120C (pt) |
| CY (2) | CY1112958T1 (pt) |
| DK (2) | DK2389937T3 (pt) |
| ES (2) | ES2685923T3 (pt) |
| HU (1) | HUE041842T2 (pt) |
| IL (1) | IL165589A (pt) |
| MX (1) | MXPA04012534A (pt) |
| NO (1) | NO333504B1 (pt) |
| NZ (1) | NZ537090A (pt) |
| PL (1) | PL217394B1 (pt) |
| PT (2) | PT2389937T (pt) |
| SI (2) | SI2389937T1 (pt) |
| TR (1) | TR201816386T4 (pt) |
| WO (1) | WO2003105830A1 (pt) |
| ZA (1) | ZA200409901B (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0213393B8 (pt) * | 2001-10-19 | 2021-05-25 | Fujifilm Toyama Chemical Co Ltd | derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica |
| CN100375619C (zh) | 2002-06-14 | 2008-03-19 | 富山化学工业株式会社 | 改善脑功能的药物组合物及其用途 |
| CA2521648C (en) * | 2003-04-17 | 2012-07-03 | Toyama Chemical Co., Ltd. | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| US7435837B2 (en) | 2003-10-24 | 2008-10-14 | Wyeth | Dihydrobenzofuranyl alkanamine derivatives and methods for using same |
| EP2258358A3 (en) * | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| MX2008013728A (es) * | 2006-04-26 | 2009-01-07 | Toyama Chemical Co Ltd | Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo. |
| US8119625B2 (en) * | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| SI2048145T1 (sl) * | 2006-08-04 | 2011-04-29 | Toyama Chemical Co Ltd | Spodbujevalec aktivnosti proteinske kinaze c, vsebujoäś derivat alkilnega etra ali sol le-tega |
| US20090221554A1 (en) * | 2008-02-28 | 2009-09-03 | Zenyaku Kogyo Kabushiki Kaisha | Method of treating cognitive impairment |
| CN102046620B (zh) * | 2008-05-28 | 2014-04-09 | 富山化学工业株式会社 | 新的苯并噻吩氧化物衍生物及其盐 |
| ES2694202T3 (es) | 2012-07-12 | 2018-12-19 | Concert Pharmaceuticals, Inc. | Idebenona deuterada |
| EP3100725B1 (en) * | 2014-01-31 | 2020-05-06 | FUJIFILM Toyama Chemical Co., Ltd. | Post nerve injury rehabilitation effect-enhancing agent comprising an alkyl ether derivative or a salt thereof |
| BR112019024851A2 (pt) * | 2017-06-02 | 2020-06-09 | Fujifilm Toyama Chemical Co Ltd | agente para evitar ou tratar atrofia cerebral |
| EP3632430A4 (en) | 2017-06-02 | 2020-06-10 | FUJIFILM Toyama Chemical Co., Ltd. | AGENT FOR THE PREVENTION OR TREATMENT OF SPINOCEREBELLOUS ATAXIA |
| KR20200003102A (ko) | 2017-06-02 | 2020-01-08 | 후지필름 도야마 케미컬 가부시키가이샤 | 아밀로이드 β 단백질량 감소제 |
| JP7370859B2 (ja) | 2017-06-02 | 2023-10-30 | 富士フイルム富山化学株式会社 | タウオパチー予防または治療剤 |
| JPWO2018221728A1 (ja) * | 2017-06-02 | 2020-04-02 | 富士フイルム富山化学株式会社 | アルツハイマー型認知症予防または治療剤 |
| SG11202000193UA (en) * | 2017-07-08 | 2020-02-27 | Massachusetts Gen Hospital | Screening platform to identify therapeutic drugs or agents for treatment of alzheimer's disease |
| EP3705121B1 (en) | 2017-10-30 | 2023-08-30 | FUJIFILM Toyama Chemical Co., Ltd. | Emopamil binding protein binding agent and use thereof |
| CN110464834B (zh) * | 2019-09-04 | 2022-12-02 | 北京豪思生物科技股份有限公司 | 铜蓝蛋白联合多奈哌齐的应用 |
| KR20220040291A (ko) | 2020-09-23 | 2022-03-30 | 씨엔지바이오 주식회사 | 4-메톡시-2-펜에틸이소인돌린-1-온 유도체 및 이를 포함하는 신경질환의 치료용 조성물 |
| KR20220040294A (ko) | 2020-09-23 | 2022-03-30 | 씨엔지바이오 주식회사 | 6-메톡시-2-펜에틸이소인돌린-1-온 유도체 및 이를 포함하는 신경질환의 치료용 조성물 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL74497A (en) | 1985-03-05 | 1990-02-09 | Proterra Ag | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
| US5177082A (en) | 1985-11-05 | 1993-01-05 | Yu Chao Mei | Huperzines and analogs |
| US4663318A (en) | 1986-01-15 | 1987-05-05 | Bonnie Davis | Method of treating Alzheimer's disease |
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| JPH0210827A (ja) | 1988-06-29 | 1990-01-16 | Matsushita Electron Corp | 半導体装置の製造方法 |
| US5280032A (en) | 1989-02-14 | 1994-01-18 | Toyama Chemical Co., Ltd. | 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
| JP2887492B2 (ja) | 1990-02-05 | 1999-04-26 | 富山化学工業株式会社 | １，２―エタンジオール誘導体およびその塩 |
| JP2913196B2 (ja) | 1989-04-26 | 1999-06-28 | 富山化学工業株式会社 | １，２−エタンジオール誘導体またはその塩 |
| NZ232493A (en) * | 1989-02-14 | 1992-06-25 | Toyama Chemical Co Ltd | Aryl- or heterocyclyl-substituted 1,2-ethanediol derivatives and pharmaceutical compositions |
| US4914102A (en) * | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
| JP3044055B2 (ja) | 1990-08-09 | 2000-05-22 | 富山化学工業株式会社 | １，２―エタンジオール誘導体およびその塩 |
| JPH0676401B2 (ja) | 1990-10-19 | 1994-09-28 | エスエス製薬株式会社 | キノリン誘導体及びこれを含有する医薬 |
| TW197435B (pt) | 1990-11-22 | 1993-01-01 | Takeda Pharm Industry Co Ltd | |
| DE4111861A1 (de) | 1991-04-11 | 1992-10-15 | Schwabe Willmar Gmbh & Co | Benzopyranone, verfahren zu ihrer herstellung und verwendung |
| JP2925363B2 (ja) | 1991-07-09 | 1999-07-28 | キヤノン株式会社 | 画像処理方法及び装置 |
| DE4136288A1 (de) * | 1991-11-04 | 1993-05-06 | Troponwerke Gmbh & Co Kg, 5000 Koeln, De | Kombination von calciumantagonisten mit cholinesterase-inhibitoren |
| JP3232830B2 (ja) | 1993-11-30 | 2001-11-26 | 三菱電機株式会社 | フレキシブルディスク装置のキャリッジ機構 |
| DE69531877T2 (de) | 1994-10-25 | 2004-07-29 | Toyama Chemical Co. Ltd. | Ein Wirkstoff für die Forderung von Nervwachstumfaktor Aktivität, der ein 1,2-Ethandiol-Derivat oder ein Salz davon enthält |
| US5889006A (en) | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| IL117149A0 (en) | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| WO1997030703A1 (fr) * | 1996-02-20 | 1997-08-28 | Toyama Chemical Co., Ltd. | Agent ameliorant les fonctions cerebrales contenant des derives de 1,2-ethanediol ou des sels de celui-ci |
| WO1998001425A1 (en) * | 1996-07-10 | 1998-01-15 | Schering Corporation | 1,4-di-sustituted piperidines as muscarinic antagonists |
| SK20199A3 (en) * | 1996-08-15 | 2000-03-13 | Schering Corp | Ether muscarinic antagonists |
| JPH10259126A (ja) | 1997-01-17 | 1998-09-29 | Takeda Chem Ind Ltd | アルツハイマー病治療・予防剤 |
| US20030092737A1 (en) | 1997-11-14 | 2003-05-15 | Pierre Maffrand Jean | Combination of active ingredients for the treatment of senile dementia of the Alzheimer type |
| CO4980891A1 (es) | 1997-11-14 | 2000-11-27 | Sanofi Sa | Asociacion de principios activos para el tratamiento de la demencia senil de tipo azheimer |
| WO1999031056A1 (fr) * | 1997-12-12 | 1999-06-24 | Toyama Chemical Co., Ltd. | Derives d'ether alcoylique ou leurs sels, et antagonistes du calcium les contenant |
| HU229250B1 (en) | 1999-06-11 | 2013-10-28 | Toyama Chemical Co Ltd | N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| BRPI0213393B8 (pt) | 2001-10-19 | 2021-05-25 | Fujifilm Toyama Chemical Co Ltd | derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica |
| CN100375619C (zh) | 2002-06-14 | 2008-03-19 | 富山化学工业株式会社 | 改善脑功能的药物组合物及其用途 |
| CA2521648C (en) | 2003-04-17 | 2012-07-03 | Toyama Chemical Co., Ltd. | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| MX2008013728A (es) | 2006-04-26 | 2009-01-07 | Toyama Chemical Co Ltd | Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo. |
| US8119625B2 (en) | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
-
2003
- 2003-04-03 CN CNB038138573A patent/CN100375619C/zh not_active Expired - Lifetime
- 2003-04-03 US US12/683,813 patent/USRE42327E1/en not_active Expired - Lifetime
- 2003-04-03 AU AU2003236364A patent/AU2003236364C1/en not_active Expired
- 2003-04-03 PL PL372934A patent/PL217394B1/pl unknown
- 2003-04-03 DK DK11006318.7T patent/DK2389937T3/en active
- 2003-04-03 BR BRPI0311780A patent/BRPI0311780B8/pt not_active IP Right Cessation
- 2003-04-03 PT PT11006318T patent/PT2389937T/pt unknown
- 2003-04-03 MX MXPA04012534A patent/MXPA04012534A/es active IP Right Grant
- 2003-04-03 WO PCT/JP2003/004292 patent/WO2003105830A1/ja active Application Filing
- 2003-04-03 DK DK03760132.5T patent/DK1514542T3/da active
- 2003-04-03 JP JP2004512734A patent/JP4675103B2/ja not_active Expired - Lifetime
- 2003-04-03 CA CA2488120A patent/CA2488120C/en not_active Expired - Lifetime
- 2003-04-03 TR TR2018/16386T patent/TR201816386T4/tr unknown
- 2003-04-03 KR KR1020047020053A patent/KR100935615B1/ko active IP Right Grant
- 2003-04-03 PT PT03760132T patent/PT1514542E/pt unknown
- 2003-04-03 ES ES11006318.7T patent/ES2685923T3/es not_active Expired - Lifetime
- 2003-04-03 US US10/516,320 patent/US7342043B2/en not_active Ceased
- 2003-04-03 EP EP03760132A patent/EP1514542B1/en not_active Expired - Lifetime
- 2003-04-03 SI SI200332578T patent/SI2389937T1/sl unknown
- 2003-04-03 SI SI200332141T patent/SI1514542T1/sl unknown
- 2003-04-03 EP EP11006318.7A patent/EP2389937B1/en not_active Expired - Lifetime
- 2003-04-03 AT AT03760132T patent/ATE546140T1/de active
- 2003-04-03 NZ NZ537090A patent/NZ537090A/en not_active IP Right Cessation
- 2003-04-03 HU HUE11006318A patent/HUE041842T2/hu unknown
- 2003-04-03 ES ES03760132T patent/ES2379948T3/es not_active Expired - Lifetime
- 2003-04-03 IL IL165589A patent/IL165589A/en active IP Right Grant
-
2004
- 2004-11-25 NO NO20045158A patent/NO333504B1/no not_active IP Right Cessation
- 2004-12-07 ZA ZA200409901A patent/ZA200409901B/xx unknown
-
2007
- 2007-12-17 US US11/957,832 patent/US7834053B2/en not_active Expired - Lifetime
-
2012
- 2012-05-08 CY CY20121100432T patent/CY1112958T1/el unknown
-
2018
- 2018-08-21 CY CY181100871T patent/CY1120591T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120591T1 (el) | Ιατρικη συνθεση για βελτιωση λειτουργιας εγκεφαλου | |
| PT1259489E (pt) | Compostos azapoliciclicos condensados con arilo. | |
| BG105365A (en) | Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents | |
| UA83899C2 (uk) | Сполуки імідазолу для лікування нейродегенеративних розладів | |
| CA2501799A1 (en) | Pyrazole compounds for treatment of neurodegenerative disorders | |
| MY140835A (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists | |
| CA2534532A1 (en) | Compounds for the treatment of neurodegenerative disorders | |
| ATE119885T1 (de) | 1,2,3,4-tetrahydro-9-akridinaminderivate. | |
| TW200509933A (en) | Therapeutic agents | |
| WO2005095348A3 (en) | Pyrazole-amine compounds for the treatment of neurodegenerative disorders | |
| DE69822937D1 (de) | Indolmorphinan-derivate und medikamente zur behandlung/mittel zur vorbeugung von cerebralen störungen | |
| ATE421961T1 (de) | Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält | |
| ZA891769B (en) | Heterocyclic compounds | |
| WO2005095361A8 (en) | Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders | |
| DK0950053T3 (da) | Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater |